Cyclotriphosphazene, a scaffold for 19F MRI contrast agents
| dc.contributor.author | Onal, Emel | |
| dc.contributor.author | Zhang, Cheng | |
| dc.contributor.author | Davarci, Derya | |
| dc.contributor.author | Isci, Umit | |
| dc.contributor.author | Pilet, Guillaume | |
| dc.contributor.author | Whittaker, Andrew K. | |
| dc.contributor.author | Dumoulin, Fabienne | |
| dc.date.accessioned | 2025-10-29T11:21:20Z | |
| dc.date.issued | 2018 | |
| dc.department | Gebze Teknik Üniversitesi | |
| dc.description.abstract | A cyclotriphosphazene substituted with six 3,5-bis(trifluoromethyl) benzyloxy units was designed as a novel F-19 MRI contrast agent. The resulting molecule has 36 magnetically equivalent fluorine atoms and exhibited suitable MRI properties with high imaging sensitivity, confirming the proof-of-concept as a convenient scaffold for the production of new F-19 MRI contrasts agents. (C) 2017 Elsevier Ltd. All rights reserved. | |
| dc.description.sponsorship | Turkish Academy of Sciences | |
| dc.description.sponsorship | Australian Research Council [CE140100036] | |
| dc.description.sponsorship | Australian Research Council [CE140100036] Funding Source: Australian Research Council | |
| dc.description.sponsorship | F.D. thanks the Turkish Academy of Sciences for partial support. A.W. and C.Z. acknowledge the Australian Research Council (CE140100036) for funding of this research. We also acknowledge use of equipment managed by the Australian National Fabrication Facility, Queensland Node. | |
| dc.identifier.doi | 10.1016/j.tetlet.2017.12.032 | |
| dc.identifier.endpage | 523 | |
| dc.identifier.issn | 0040-4039 | |
| dc.identifier.issn | 1873-3581 | |
| dc.identifier.issue | 6 | |
| dc.identifier.orcid | 0000-0002-2722-7497 | |
| dc.identifier.orcid | 0000-0002-6285-0524 | |
| dc.identifier.orcid | 0000-0002-0388-8338 | |
| dc.identifier.orcid | 0000-0002-0407-9604 | |
| dc.identifier.scopus | 2-s2.0-85039840131 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 521 | |
| dc.identifier.uri | https://doi.org/10.1016/j.tetlet.2017.12.032 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14854/8990 | |
| dc.identifier.volume | 59 | |
| dc.identifier.wos | WOS:000424853400006 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Pergamon-Elsevier Science Ltd | |
| dc.relation.ispartof | Tetrahedron Letters | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20251020 | |
| dc.subject | F-19 MRI | |
| dc.subject | Cyclotriphosphazene | |
| dc.subject | Contrast agent | |
| dc.title | Cyclotriphosphazene, a scaffold for 19F MRI contrast agents | |
| dc.type | Article |








